Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

2,206 questions in 117 reviews · Common Mental Disorders

current versions
No studies 387 · 17.5%Ungraded 111 · 5%Very low 635 · 28.8%Low 568 · 25.7%Moderate 449 · 20.4%High 56 · 2.5%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Therapist‐supported ICBT vs waiting list, attention, information, or online discussion group only control
Quality of life at post‐treatment Indexed by self‐report measures of quality of life or functional disability · patients with anxiety disorders
Therapist‐supported Internet cognitive behavioural therapy for anxiety disorders in adults (2016) · Cochrane
no estimate extracted23 studies · 1639 participantsModerate
Therapist‐supported ICBT vs waiting list, attention, information, or online discussion group only control
Adverse events at post‐treatment not reported · patients with anxiety disorders
Therapist‐supported Internet cognitive behavioural therapy for anxiety disorders in adults (2016) · Cochrane
no estimate extracted0 studies · 0 participantsUngraded
Therapist‐supported ICBT vs waiting list, attention, information, or online discussion group only control
Participant satisfaction Indexed by a mix of qualitative and quantitative self‐report measures · patients with anxiety disorders
Therapist‐supported Internet cognitive behavioural therapy for anxiety disorders in adults (2016) · Cochrane
no estimate extracted0 studies · 13 participantsUngraded
Therapist‐supported ICBT vs unguided CBT
Clinically important improvement in anxiety at post‐treatment Indexed by a standardized interview or clinically accepted measure cut‐off score1 · patients with anxiety disorders
Therapist‐supported Internet cognitive behavioural therapy for anxiety disorders in adults (2016) · Cochrane
no estimate extracted1 study · 54 participantsVery low
Therapist‐supported ICBT vs unguided CBT
Disorder‐specific anxiety symptom severity at post‐treatment Indexed by a range of disorder‐specific self‐report measures · patients with anxiety disorders
Therapist‐supported Internet cognitive behavioural therapy for anxiety disorders in adults (2016) · Cochrane
no estimate extracted5 studies · 312 participantsVery low
Therapist‐supported ICBT vs unguided CBT
General anxiety symptom severity at post‐treatment Indexed by a range of measures of anxiety symptoms in general · patients with anxiety disorders
Therapist‐supported Internet cognitive behavioural therapy for anxiety disorders in adults (2016) · Cochrane
no estimate extracted2 studies · 138 participantsVery low
Antidepressants vs benzodiazepines
failure to respond · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 0.99 [0.67, 1.47]2 studies · 215 participantsLow
TCAs vs benzodiazepines
panic symptoms ‐ endpoint score · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
no estimate extracted2 studies · 998 participantsVery low
TCAs vs benzodiazepines
panic symptoms ‐ mean change · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
no estimate extracted1 study · 44 participantsLow
TCAs vs benzodiazepines
number of dropouts due to adverse effects · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 2.1 [1.13, 3.93]2 studies · 848 participantsLow
SSRIs vs benzodiazepines
failure to respond · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 0.93 [0.48, 1.8]1 study · 154 participantsVery low
SSRIs vs benzodiazepines
total number of dropouts · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 1.71 [1.03, 2.84]1 study · 154 participantsVery low
SSRIs vs benzodiazepines
failure to remit · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 1.12 [0.79, 1.59]1 study · 154 participantsVery low
SSRIs vs benzodiazepines
panic symptoms · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
no estimate extracted1 study · 146 participantsLow
SSRIs vs benzodiazepines
number of dropouts due to adverse effects · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 1.2 [0.55, 2.61]1 study · 154 participantsVery low
TCAs vs SSRI
failure to respond · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 1.08 [0.71, 1.66]4 studies · 438 participantsLow
TCAs vs SSRI
total number of dropouts · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 0.98 [0.65, 1.48]7 studies · 928 participantsLow
Antidepressants vs benzodiazepines
total number of dropouts · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 1.64 [1.03, 2.63]7 studies · 1449 participantsVery low
TCAs vs SSRI
failure to remit · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 0.89 [0.63, 1.26]5 studies · 475 participantsModerate
TCAs vs SSRI
panic symptoms · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
no estimate extracted4 studies · 243 participantsVery low
TCAs vs SSRI
number of dropouts due to adverse effects · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 1.43 [0.82, 2.48]5 studies · 476 participantsLow
TCA vs MAOI
failure to respond · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 0.59 [0.28, 1.26]1 study · 135 participantsLow
TCA vs MAOI
total number of dropouts · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 0.84 [0.61, 1.17]2 studies · 228 participantsModerate
TCA vs MAOI
failure to remit · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
no estimate extracted0 studies · 0 participantsUngraded
TCA vs MAOI
panic symptoms · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
no estimate extracted1 study · 135 participantsLow
TCA vs MAOI
number of dropouts due to adverse events · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 1.27 [0.5, 3.21]1 study · 135 participantsLow
SSRIs vs MAOIs
failure to respond · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 1.12 [0.83, 1.52]2 studies · 396 participantsModerate
SSRIs vs MAOIs
total number of dropouts · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 1 [0.07, 14.55]1 study · 30 participantsLow
Antidepressants vs benzodiazepines
failure to remit · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 1.18 [1.01, 1.37]3 studies · 1002 participantsModerate
SSRIs vs MAOIs
failure to remit · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 0.93 [0.74, 1.17]1 study · 366 participantsModerate
SSRIs vs MAOIs
panic symptoms · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
no estimate extracted0 studies · 0 participantsUngraded
SSRIs vs MAOIs
number of dropouts due to adverse events · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 1.26 [0.59, 2.7]1 study · 366 participantsLow
SSRIs vs SNRIs
failure to respond · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 0.96 [0.75, 1.23]2 studies · 991 participantsHigh
SSRIs vs SNRIs
total number of dropouts · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 1.11 [0.74, 1.65]2 studies · 991 participantsLow
SSRIs vs SNRIs
failure to remit · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 1.05 [0.91, 1.21]2 studies · 991 participantsHigh
SSRIs vs SNRIs
panic symptoms · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
no estimate extracted2 studies · 945 participantsHigh
SSRIs vs SNRIs
number of dropouts due to adverse effects · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 1.86 [0.49, 7.05]2 studies · 991 participantsLow
SSRIs vs NaSSAs
failure to respond · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
no estimate extracted0 studies · 0 participantsUngraded
SSRIs vs NaSSAs
total number of dropouts · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 1.5 [0.29, 7.73]1 study · 30 participantsLow
Antidepressants vs benzodiazepines
panic symptoms ‐ endpoint score · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
no estimate extracted3 studies · 1144 participantsVery low
SSRIs vs NaSSAs
failure to remit · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
no estimate extracted0 studies · 0 participantsUngraded
SSRIs vs NaSSAs
panic symptoms · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
no estimate extracted1 study · 22 participantsLow
SSRIs vs NaSSAs
number of dropouts due to adverse events · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 1.5 [0.29, 7.73]1 study · 30 participantsLow
Antidepressants vs benzodiazepines
panic symptoms ‐mean change · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
no estimate extracted1 study · 44 participantsLow
Antidepressants vs benzodiazepines
number of dropouts due to adverse effects · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 1.72 [1.03, 2.87]3 studies · 1002 participantsLow
TCAs vs benzodiazepines
failure to respond · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 1.02 [0.63, 1.67]1 study · 61 participantsVery low
TCAs vs benzodiazepines
total number of dropouts · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 1.67 [0.93, 2.99]6 studies · 1295 participantsVery low
TCAs vs benzodiazepines
failure to remit · adults with panic disorder
Antidepressants and benzodiazepines for panic disorder in adults (2016) · Cochrane
RR 1.19 [1, 1.41]2 studies · 848 participantsModerate
Comparison 1: CBT‐based psychotherapy vs treatment
Repetition of SH at post‐intervention · adults who engage in SH
Psychosocial interventions for self‐harm in adults (2016) · Cochrane
OR 0.66 [0.36, 1.21]1 study · 313 participantsLow
Comparison 2: Interventions for multiple repetition of SH/probable personality disorder vs treatment
DBT vs TAU · adults who engage in SH
Psychosocial interventions for self‐harm in adults (2016) · Cochrane
no estimate extractedNRNo studies